The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer-Reference-Cited by-同舟云学术

The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer

Published:2021-03-28 Issue:5 Volume:21 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Okazaki Satoshi¹,Sasaki Takaaki¹,Yasuda Shunsuke¹,Abe Masahiro¹,Yoshida Nana¹,Yoshida Ryohei¹,Ishibashi Kei¹,Minami Yoshinori¹,Okumura Shunsuke¹,Chiba Shinichi²,Takei Hidehiro³,Hayashi Ryusuke⁴,Nagato Toshihiro⁴,Kobayashi Hiroya⁵,Sugitani Ayumu⁶,Ono Yusuke⁶,Mizukami Yusuke⁶,Kitada Masahiro¹,Ohsaki Yoshinobu¹

Affiliation:

1. Respiratory Center, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan

2. Center for Advanced Research and Education, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510

3. Department of Surgical Pathology, Asahikawa Medical University Hospital, Asahikawa, Hokkaido 078-8510, Japan

4. Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan

5. Department of Pathology, Asahikawa Medical University, Asahikawa, Hokkaido 078-8510, Japan

6. Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Hokkaido 065-0033, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications;International Journal of Molecular Sciences;2023-06-02

2. Circulating Tumor DNA as a Novel Biomarker Optimizing Treatment for Triple Negative Breast Cancer;Clinical Breast Cancer;2023-06

3. Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer;International Journal of Molecular Sciences;2023-04-08

4. An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer;International Journal of Molecular Sciences;2023-01-16

5. The Clinical Utility of Droplet Digital PCR for Profiling Circulating Tumor DNA in Breast Cancer Patients;Diagnostics;2022-12-05